567 related articles for article (PubMed ID: 10848874)
1. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
2. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio ; Pizzocaro ; Liberati ; De Nicolao ; Veldhuis ; Faglia
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-712. PubMed ID: 28796358
[TBL] [Abstract][Full Text] [Related]
3. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
[TBL] [Abstract][Full Text] [Related]
5. Elevation of plasma immunoreactive luteinizing hormone releasing hormone in hyperprolactinemic-amenorrheic women on bromocriptine therapy.
Elkind-Hirsch KE; Platia MP; Schiff I
J Reprod Med; 1987 Jan; 32(1):5-9. PubMed ID: 3550065
[TBL] [Abstract][Full Text] [Related]
6. The role of serum PRL bioactivity evaluation in hyperprolactinaemic women with different menstrual disorders.
Kostrzak A; Warenik-Szymankiewicz A; Meczekalski B
Gynecol Endocrinol; 2009 Dec; 25(12):799-806. PubMed ID: 19905999
[TBL] [Abstract][Full Text] [Related]
7. Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea.
Tay CC; Glasier AF; Illingworth PJ; Baird DT
Clin Endocrinol (Oxf); 1993 Nov; 39(5):599-606. PubMed ID: 8252751
[TBL] [Abstract][Full Text] [Related]
8. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
[TBL] [Abstract][Full Text] [Related]
9. Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea an the response to bromocriptine therapy.
Moult PJ; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1982 Feb; 16(2):153-62. PubMed ID: 6802531
[TBL] [Abstract][Full Text] [Related]
10. [Pulsatile secretion of prolactin during the human menstrual cycle].
Masaoka K; Kitazawa M; Niibe T; Kumasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1793-9. PubMed ID: 3209907
[TBL] [Abstract][Full Text] [Related]
11. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of LH and prolactin pulses in normoprolactinemic women with ovulatory disturbances and variation of LH and FSH pulses and secreting capacity by administration of bromocriptine in the same cases].
Kato K; Watanabe R; Ito E; Sakamoto T; Morishima M; Hoshino K; Tanaka M; Tadokoro N
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2241-50. PubMed ID: 3100705
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.
Popovic V; Simic M; Ilic L; Micic D; Damjanovic S; Djurovic M; Obradovic S; Dieguez C; Casanueva F
Clin Endocrinol (Oxf); 1998 Jan; 48(1):103-8. PubMed ID: 9509075
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up.
Berinder K; Stackenäs I; Akre O; Hirschberg AL; Hulting AL
Clin Endocrinol (Oxf); 2005 Oct; 63(4):450-5. PubMed ID: 16181238
[TBL] [Abstract][Full Text] [Related]
15. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
[TBL] [Abstract][Full Text] [Related]
16. Regulation of pulsatile secretion of progesterone during the human luteal phase.
Steele PA; Braund W; Judd SJ
Clin Reprod Fertil; 1986 Apr; 4(2):117-24. PubMed ID: 3742433
[TBL] [Abstract][Full Text] [Related]
17. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
18. [Hyperprolactinemia and disorders of the menstrual cycle].
Topalski-Fistes N; Bujas M; Maticki-Sekulić M; Suvacarev S
Med Pregl; 1999; 52(3-5):156-61. PubMed ID: 10518402
[TBL] [Abstract][Full Text] [Related]
19. Effects of bromocriptine administration during the follicular phase of the oestrous cycle on prolactin and gonadotrophin secretion and follicular dynamics in merino monovular ewes.
Picazo RA; González De Bulnes A; Gómez Brunet A; del Campo A; Granados B; Tresguerres J; López Sebastián A
J Reprod Fertil; 2000 Sep; 120(1):177-86. PubMed ID: 11006160
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
Glaser B; Nesher Y; Barziliai S
J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]